DEFEAT-LD - Drug discovEry and repurposing to Find a trEAtmenT for Lafora Disease  

Finanziato dall’Unione europea – Next Generation EU – PNRR M6C2 - Investimento 2.1 Valorizzazione e potenziamento della ricerca biomedica del SSN.

Proteoglycan-4 as coadjuvant treatment to overcome resistance to sorafenib and Regorafenib in patients with Hepatocellular carcinoma  

Proof Of Concept (POC) - PNRR M6/C2 2023